Bafna Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on November 06, 2015, to consider the Un-Audited Financial Results for the Quarter ending September 30, 2015. Further, the Company confirms that as per the Company’s internal code for Prevention of Insider Trading, the Trading window for the dealing in the securities of the Company by the Directors and Employees will remain closed from the date of receipt of this communication till 48 hours after the announcement of the results made to the public.
The above information is a part of company’s filings submitted to BSE.
